Dazed and Confused: 6 CBD Myths and Realities

Slideshow

Help patients sift through the barrage of misinformation, half-truths, and unproven evidence to set them straight about CBD. 

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
FDA Expands Evolocumab Indication to Adults at Risk for Major Cardiovascular Events Due to Uncontrolled LDL-C

FDA Expands Evolocumab Indication to Adults at Risk for Major Cardiovascular Events Due to Uncontrolled LDL-C

Sydney Jennings
August 26th 2025
Article
2025 AAD Atopic Dermatitis Update: Linda Stein Gold, MD, on New Topical and Biologic Therapies

2025 AAD Atopic Dermatitis Update: Linda Stein Gold, MD, on New Topical and Biologic Therapies

Linda Stein Gold, MD;Sydney Jennings
August 26th 2025
Podcast
Lilly’s Oral GLP-1 Orforglipron Meets Endpoints in Phase 3 Obesity and Diabetes Trial

Lilly’s Oral GLP-1 Orforglipron Meets Endpoints in Phase 3 Obesity and Diabetes Trial

Sydney Jennings
August 26th 2025
Article
Countering Vaccine Misinformation in Clinical Practice with Amesh Adalja, MD: Primary Viewpoints Podcast

Countering Vaccine Misinformation in Clinical Practice with Amesh Adalja, MD: Primary Viewpoints Podcast

Amesh Adalja, MD;Sydney Jennings
August 26th 2025
Podcast
Semaglutide 2.4 mg Approved for Treatment of MASH Without Cirrhosis: Daily Dose / image credit: ©New Africa/AdobeStock

Semaglutide 2.4 mg Approved for Treatment of MASH Without Cirrhosis: Daily Dose

Sydney Jennings
August 26th 2025
Article
FDA Clears First Over-The-Counter CGM for Weight Management From Signos / image credit ©lukszczepanski/stock.adobe.com

Signos Wins Clearance for First Over-The-Counter CGM for Weight Management

Grace Halsey
August 26th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.